Genetic Technology Alert. Personalized Treatment for Prostate Cancer Patients; Personal Genomics Paves the Way for Future Medicine and Health; Gene Therapy for Ophthalmic Diseases

USD 250

* Required Fields

USD 250

PAY BY INVOICE

Be the first to review this product

This issue profiles personalized treatment for prostate cancer patients, personal genomics that paves the way for future medicine and health, and gene therapy for ophthalmic diseases.

Table of Contents

Genetic Technology Alert. Personalized Treatment for Prostate Cancer Patients; Personal Genomics Paves the Way for Future Medicine and Health; Gene Therapy for Ophthalmic DiseasesIn This Issue1. PERSONALIZED TREATMENT FOR PROSTATE CANCER PATIENTS2. PERSONAL GENOMICS PAVES THE WAY FOR FUTURE MEDICINE AND HEALTH3. GENE THERAPY FOR OPHTHALMIC DISEASES4. RECENT PATENTS IN GENETIC TECHNOLOGY IN INDIA




Related Research

Release Date : 31-Mar-14

Region : Global

Release Date : 30-Jun-2007

Region : Global

Release Date : 31-Dec-2005

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.